Business / Finance

RSS

QRxPharma, Actavis enter License and Option Agreement

QRxPharma Limited announced today execution of its License and Option Agreement with Actavis, Inc. which finalised the legal terms and conditions to commercialise MoxDuo IR in the US acute pain marketplace. The LOA completion follows a 20 December 2011 signing of a binding Letter of Intent secured by a US$6 million non-refundable upfront signing fee to QRxPharma.

19 Mar 2012

XTL Biopharmaceuticals completes $2.4 million private placement of securities

XTL Biopharmaceuticals announced yesterday, March 18, 2012, it successfully completed a private placement of securities with foreign as well as Israeli institutional and private investors for a total of $2.4 million (NIS 9.1 million).

19 Mar 2012

inVentiv Health enters agreement to acquire Kforce Clinical Research

inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.

19 Mar 2012

Covidien to acquire superDimension

Covidien, a leading global provider of healthcare products, today announced a definitive agreement to acquire superDimension, Ltd., a private company based in Herzliya, Israel, that develops minimally invasive interventional pulmonology devices.

19 Mar 2012

China Botanic first quarter net sales increase 24.4% to $28.1M

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China, today announced financial results for the three months ended January 31, 2012.

19 Mar 2012

RBCC's new agreement with n3D could help develop stem-cell therapies

As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences' new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.

19 Mar 2012

Kanghui fourth quarter total net revenue increases 33.6% to RMB96.6M

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its unaudited financial results for the fourth quarter and full year 2011.

19 Mar 2012

Sanofi enters definitive agreement to acquire Pluromed

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.

17 Mar 2012

Kensey Nash to resolve Angio-Seal license disputes with St. Jude Medical

Kensey Nash Corporation today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims.

17 Mar 2012

OncoGenex prices underwritten public offering of 4,165,000 shares of common stock

OncoGenex Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 4,165,000 shares of its common stock at a purchase price of $12.00 per share.

17 Mar 2012

Salix closes $690 million senior notes offering

Salix Pharmaceuticals, Ltd. today announced the closing of its offering of $690 million aggregate principal amount of 1.5% convertible senior notes due 2019, which includes the exercise in full of the initial purchasers' overallotment option.

17 Mar 2012

Kips Bay Medical fourth quarter net sales decrease to $94,000

Kips Bay Medical, Inc. today announced financial results for fourth quarter and year ended December 31, 2011.

17 Mar 2012

Expanded R&D facility opens at Cubist headquarters

Cubist Pharmaceuticals, Inc. today announced the official opening of its expanded research and development facility at its headquarters at 65 Hayden Avenue in Lexington, Massachusetts.

17 Mar 2012

Baptist Health South Florida named one of 2012 World's Most Ethical Companies

Baptist Health South Florida announced today that Ethisphere Institute has named it as one of the 2012 World's Most Ethical Companies - marking the second straight such honor for Baptist Health.

17 Mar 2012

Echo total revenues increase to $447,000 for fiscal year 2011

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced financial results for the year ended December 31, 2011.

17 Mar 2012

Tarsa advances OSTORA NDA filing through $28M Series B financing

Tarsa Therapeutics, Inc. today announced completion of a $28 million Series B equity financing led by new investor Foresite Capital.

17 Mar 2012

Repligen total revenue increases to $7,165,000 for quarter ended December 31, 2011

Repligen Corporation today reported financial results for the quarter and nine-month fiscal year ended December 31, 2011.

17 Mar 2012

PURE Bioscience second quarter revenue increases to $221,000

PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for its second quarter ended January 31, 2012.

17 Mar 2012

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.

16 Mar 2012

SIPP secures necessary financing commitment from First Fidelity

SIPP International Industries, Inc., the diversified parent company to several divisions in the food, medical, hotel and broadcasting industries, has secured its necessary financing commitment from First Fidelity, Inc. for the manufacturing of the SIPP product lines.

16 Mar 2012